Home Infusion Therapy Market (By Product: Infusion Pumps, Intravenous Sets, IV Cannulas, Needleless Connectors; By Application: Anti-infective, Endocrinology, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals, Others; By Route of Administration: Intramuscular, Subcutaneously, Epidural; By End User: Patients, Nurse, Hospitals, Others)- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2022-2030

The global Home Infusion Therapy market size was estimated at USD 43.4 billion in 2021 and is expected to surpass around USD 65.2 billion by 2030 and poised to grow at a compound annual growth rate (CAGR) of 4.63% during the forecast period 2022 to 2030.

Key Takeaways:

  • North America home infusion therapy market was valued at USD 18.25 billion in 2021.
  • Based on the products, the infusion pumps portion represented the biggest income portion of more than 50.4% in 2021.
  • Based on application, the anti-infective fragment ruled the market for home infusion therapy in 2021 with an income portion of more than 25.5%.
  • North America ruled the market in 2021 with an income portion of more than 56%.
  • The Asia Pacific market is supposed to enroll the quickest CAGR of 9.7% over the figure period.

Home infusion therapy refers to the process in which patients receive treatment at home through the administration of drugs or biologicals through catheters and needles. Receiving treatment at home as opposed to hospitals or healthcare facilities is a cost-effective and more convenient option for patients, further driving the need for home infusion therapy.

Home infusion therapy involves the intravenous or subcutaneous administration of drugs or biologicals to an individual at home. Favorable government policies and regulations are expected to propel market growth. In February 2018, the Bipartisan Budget Act of 2018 was signed into a law that states that all temporary payments of home infusion therapy in the U.S. will be covered by the government in accordance with this regulation.

In addition, the rising prevalence of chronic diseases, such as cardiovascular diseases (CVDs), cancer, diabetes, and other life-threatening conditions, is expected to have a high impact on the market growth. According to a WHO report, the above-mentioned diseases accounted for 60.0% of the total deaths and 43.0% of the disease burden in the U.S. in 2019. This creates the need to infuse nutritional products that contain glutamine, phospholipids, glucose, and amino acids while administering medication to patients, which, in turn, is expected to boost the market growth in this region.

The ongoing COVID-19 pandemic is expected to create lucrative opportunities for the market. Due to the restrictions caused by COVID-19, patients are waiting to seek treatment until they feel safe. Moreover, patients who seek infusion therapy already have diseases, which eventually weaken their immune systems. In such cases, going outside even to receive treatment becomes a potential threat. Reduced operating hours have led to difficulty in scheduling appointments as well, even if patients choose to continue treatment. Hence, home infusion therapy is expected to play a key role in supporting patients.

Report Scope of the Home Infusion Therapy  Market

Report Coverage

Details

Market Size in 2022

USD 45.41 Billion

Market Size by 2030

USD 65.2 Billion

Growth Rate from 2022 to 2030

CAGR of 4.63%

Base Year

2021

Forecast Period

2022 to 2030

Segments Covered

Product, Application, Route of Administration, End User, Geography

Companies Mentioned

CVS/Coram, Option Care Health, BriovaRx/Diplomat (UnitedHealth Optum, PharMerica, Fresenius Kabi, ICU Medical, Inc., B. Braun Melsungen AG, Baxter, BD, Caesarea Medical Electronics, Smith’s Medical, Terumo Corporation, JMS Co. Ltd., Others 

 

Product Insights

The infusion pumps segment accounted for the largest revenue share of over 50.4% in 2021 as these pumps are widely preferred for the delivery of nutrients and medications. On the basis of product, the market for home infusion therapy is segmented into infusion pumps, ambulatory infusion pumps, intravenous sets, IV cannulas, and needleless connectors. The availability of a variety of products such as enteral, syringe, multichannel, and peristaltic pumps further contributes to the segment growth. The rising demand for syringes and ambulatory pumps owing to the increasing preference for home healthcare is also anticipated to contribute to the segment growth. 

Nowadays, smart pumps are widely used as these pumps contain advanced features such as barcode technology, which helps in the verification of a patient’s identity and prevents drug administration errors. Needleless connectors are anticipated to register the highest CAGR over the forecast period. These connectors offer improved safety, enable smooth surgeries, and help adhere to good clinical practice (GCP), which contributes to the growth of the segment.

Application Insights

The anti-infective segment dominated the market for home infusion therapy in 2021 with a revenue share of over 25.5%. On the basis of application, the market has been segmented into anti-infective, endocrinology, hydration therapy, chemotherapy, enteral nutrition, parenteral nutrition, and specialty pharmaceuticals. This is attributed to the considerable number of procedures performed for the administration of antifungal and antibiotic drugs. It also helps reduce exposure to patients with other hospital-acquired infections (HAIs).

Chemotherapy is estimated to be the fastest-growing segment over the forecast period. With the growing incidences of cancer, the demand for pressure pumps is expected to increase in the coming years. Pumps used for chemotherapy at home are compact, continuous pressure pumps that do not require a battery and can hence be used for a longer period of time. With the help of these pumps, chemotherapy drugs can be administered at the appropriate infusion speed and in the right amounts.

Regional Insights

North America dominated the market in 2021 with a revenue share of over 56% and this trend is expected to continue throughout the forecast period. This can be attributed to the increasing R&D in the region and the rising adoption of new technology in infusion pumps. The increasing need for long-term therapy for patients with certain conditions is driving the regional market. Development of alternate healthcare settings and home infusion services and shifting preference from acute care to home care settings due to the low cost and enhanced patient mobility would boost the growth of this market in the coming years.

The Asia Pacific market is expected to register the fastest CAGR of 9.7% over the forecast period. This is attributed to rising patient awareness regarding the benefits of home infusion therapy over in-hospital procedures and the growing prevalence of diabetes in the region. The growing geriatric population and the rise in chronic diseases in the region are expected to further fuel the market growth. According to the Times of India, around 75 million people over the age of 60 years suffer from some chronic disease in India, which might increase the adoption of home care services in the country.

Some of the prominent players in the Home Infusion Therapy  Market include:

  • CVS/Coram
  • Option Care Health
  • BriovaRx/Diplomat (UnitedHealth Optum)
  • PharMerica
  • Fresenius Kabi
  • ICU Medical, Inc.
  • B. Braun Melsungen AG
  • Baxter
  • BD
  • Caesarea Medical Electronics
  • Smith’s Medical
  • Terumo Corporation
  • JMS Co. Ltd.
  • Others 

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global Home Infusion Therapy  market

By Product

  • Infusion Pumps
    • Elastomeric
    • Electromechanical
    • Gravity
    • Others
  • Intravenous Sets
  • IV Cannulas
  • Needleless Connectors 

By Application

  • Anti-infective
  • Endocrinology
    • Diabetes
    • Others
  • Hydration Therapy
    • Athletes
    • Others
  • Chemotherapy
  • Enteral Nutrition
  • Parenteral Nutrition
  • Specialty Pharmaceuticals
  • Others

By Route of Administration

  • Intramuscular
  • Subcutaneously
  • Epidural

By End User

  • Patients
  • Nurse
  • Hospitals
  • Others 

By Geography

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • United Kingdom
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Southeast Asia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Rest of Latin America

Middle East & Africa (MEA)

  • GCC
  • North Africa
  • South Africa
  • Rest of Middle East & Africa

Key Benefits for Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the global Home Infusion Therapy  industry analysis from 2022 to 2030 to identify the prevailing Home Infusion Therapy  industry opportunity.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the global Home Infusion Therapy  industry segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global Home Infusion Therapy  industry trends, key players, market segments, application areas, and market growth strategies.